Predictmedix's Dr. Kushwah on how AI technology for mass screening of COVID-19 is here
Channel: InvestorCoffee
Date: 2020-05-18

"We have developed a technology to screening for COVID-19 and the key is, it is a mass screening technology. The technology works with multispectral imaging and our AI algorithms, which are patent pending and sit on a cloud, and they communicate directly with the multispectral cameras. These cameras can be installed and as people are passing by, the technology will just screen them for COVID-19." States Dr. Rahul Kushwah, Co-Founder and COO of Predictmedix Inc. (CSE: PMED | OTCQB: PMEDF), in an interview with InvestorIntel’s Tracy Weslosky.

Dr. Kushwah went on to say that the technology can be deployed in places where there is movement of large number of people like airports, shopping centers, malls, arenas, transit hubs, etc. He added, "If you want to control the next wave you have to ensure that there is no transmission of infection and the only way you can do that is by containment and to contain you have to identify."

Dr. Kushwah also provided an update on the appointment of Microsoft Director of Business Development for AI solutions, Kapil Raval, as the Chairman of the Advisory Board. He said that Predictmedix is working very closely with the Indian Institute of Technology to scale up its technologies. Dr. Kushwah also said that Predictmedix has deployed its mass screening technology for COVID-19 with Max Healthcare. He continued, "Max Healthcare is one the largest healthcare group in South Asia...They have 14 hospitals with over 3000 doctors, and we have deployed our technology at their facilities. That is a phenomenal validation to what we have developed."

Disclaimer: Predictmedix Inc. is an advertorial member of InvestorIntel Corp.